OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,069 | -2.1% | 401 | 0.0% | 0.00% | – |
| Q1 2023 | $2,113 | -29.6% | 401 | -40.8% | 0.00% | -100.0% |
| Q3 2022 | $3,000 | -94.9% | 677 | -88.5% | 0.00% | -93.3% |
| Q3 2021 | $59,000 | -49.1% | 5,900 | -28.0% | 0.02% | -42.3% |
| Q2 2021 | $116,000 | -1.7% | 8,200 | +13.9% | 0.03% | -3.7% |
| Q1 2021 | $118,000 | +51.3% | 7,200 | +92.1% | 0.03% | +42.1% |
| Q4 2020 | $78,000 | +239.1% | 3,748 | +24.9% | 0.02% | +216.7% |
| Q3 2020 | $23,000 | -50.0% | 3,000 | -45.2% | 0.01% | -57.1% |
| Q2 2020 | $46,000 | +820.0% | 5,478 | +447.8% | 0.01% | +600.0% |
| Q1 2020 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |